Evista to PREVENT breast cancer

More women will be taking Evista to PREVENT breast cancer.

Preliminary results of the STAR study show that Evista (raloxifene) really does work as well as tamoxifen to reduce the risk of invasive breast cancer...and it's better tolerated.

Both drugs cut the number of expected breast cancer cases from 40 to 20 per 1000 postmenopausal women.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote